Wikidata entity: Q411985
C₁₉H₂₅NOS (P274)
Quantities
| P4250 | defined daily dose | 6 |
| P2067 | mass | 315.165685 |
| P3780 | active ingredient in | ... | Q29006119 (Leganto) | Leganto |
| P3780 | active ingredient in | ... | Q29006212 (Neupro) | Neupro |
| P233 | canonical SMILES | String | CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O | ??? |
| P373 | Commons category | String | Rotigotine | ??? |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2017 | isomeric SMILES | String | CCCN(CCC1=CC=CS1)[C@H]2CCC3=C(C2)C=CC=C3O | ??? |
| P8026 | LiverTox likelihood score | ... | Q83284667 (LiverTox toxicity likelihood category E) | LiverTox toxicity likelihood category E |
| P2175 | medical condition treated | ... | Q11085 (Parkinson's disease) | Parkinson's disease |
| P2175 | medical condition treated | ... | Q916280 (restless legs syndrome) | restless legs syndrome |
| P129 | physically interacts with | ... | Q308856 (Dopamine receptor D4) | Dopamine receptor D4 |
| P129 | physically interacts with | ... | Q2034004 (Dopamine receptor D2) | Dopamine receptor D2 |
| P129 | physically interacts with | ... | Q21110867 (Dopamine receptor D1) | Dopamine receptor D1 |
| P129 | physically interacts with | ... | Q21110872 (Dopamine receptor D3) | Dopamine receptor D3 |
| P129 | physically interacts with | ... | Q21131500 (Dopamine receptor D5) | Dopamine receptor D5 |
| P769 | significant drug interaction | ... | Q422418 ((RS)-sulpiride) | (RS)-sulpiride |
| P3364 | stereoisomer of | ... | Q27284704 ((+)-rotigotine) | (+)-rotigotine |
| P279 | subclass of | ... | Q27262758 ((+/-)-rotigotine) | (+/-)-rotigotine |
| P2868 | subject has role | ... | Q600203 (dopamine agonist) | dopamine agonist |
| P2868 | subject has role | ... | Q3579672 (antiparkinson) | antiparkinson |
Why not click here or view trends?
log id: None